Dr.
Nadia Obi
  • Wissenschaftlerin
Arbeitsbereich

Kontakt

Standort

W34, 1. Etage, Raumnummer 106
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Lebenslauf

Publikationen

2018

Validation of inflammatory genetic variants associated with long-term cancer related fatigue in a large breast cancer cohort
Kühl T, Behrens S, Jung A, Obi N, Thöne K, Becher H, Chang-Claude J
BRAIN BEHAV IMMUN. 2018;73:252-260.

3.13 Menopausale Hormontherapie
Obi N
2018. Pharmakogenetik und Therapeutisches Drug Monitoring. Klein H, Haen E (Hrsg.). 1. Aufl. Berlin: De Gruyter, .

Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort
Obi N, Eulenburg C, Seibold P, Eilber U, Thöne K, Behrens S, Chang-Claude J, Flesch-Janys D
BREAST. 2018;38:75-80.

Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis
Thöne K, Rudolph A, Obi N, Chang-Claude J, Flesch-Janys D
BREAST CANCER RES TR. 2018;170(2):381-390.

2017

Determination of nasal and oropharyngeal microbiomes in a multicenter population-based study - findings from Pretest 1 of the German National Cohort
Akmatov M, Koch N, Vital M, Ahrens W, Flesch-Janys D, Fricke J, Gatzemeier A, Greiser H, Günther K, Illig T, Kaaks R, Krone B, Kühn A, Linseisen J, Meisinger C, Michels K, Moebus S, Nieters A, Obi N, Schultze A, Six-Merker J, Pieper D, Pessler F
SCI REP-UK. 2017;7(1):1855.

Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.
Akmatov M, Röber N, Ahrens W, Flesch-Janys D, Fricke J, Greiser H, Günther K, Kaaks R, Kemmling Y, Krone B, Linseisen J, Meisinger C, Moebus S, Obi N, Guzman C, Conrad K, Pessler F
ARTHRITIS RES THER. 2017;19(1):127.

2016

A Comprehensive Multistate Model Analyzing Associations of Various Risk Factors With the Course of Breast Cancer in a Population-Based Cohort of Breast Cancer Cases
Eulenburg C, Schroeder J, Obi N, Heinz J, Seibold P, Rudolph A, Chang-Claude J, Flesch-Janys D
AM J EPIDEMIOL. 2016;183(4):325-334.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort
Obi N, Heinz J, Seibold P, Vrieling A, Rudolph A, Chang-Claude J, Berger J, Flesch-Janys D
INT J CANCER. 2016;138(9):2098-2108.

2015

Diverse recruitment strategies result in different participation percentages in a web-based study, but in similar compliance
Akmatov M, Rübsamen N, Schultze A, Kemmling Y, Obi N, Günther K, Ahrens W, Pessler F, Krause G, Mikolajczyk R
INT J PUBLIC HEALTH. 2015;60(8):937-43.

2014

Test-retest reliability of an infectious disease questionnaire and evaluation of self-assessed vulnerability to infections: findings of Pretest 2 of the German National Cohort
Castell S, Akmatov M, Obi N, Flesh-Janys D, Nieters A, Kemmling Y, Pessler F, Krause G
BUNDESGESUNDHEITSBLATT. 2014;57(11):1300-7.

Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2)
Castell S, Krause G, Schmitt M, Pawlita M, Deleré Y, Obi N, Flesch-Janys D, Kemmling Y, Kaufmann A
BUNDESGESUNDHEITSBLATT. 2014;57(11):1270-6.

Determinants of newly diagnosed comorbidities among breast cancer survivors
Obi N, Gornyk D, Heinz J, Vrieling A, Seibold P, Chang-Claude J, Flesch-Janys D
J CANCER SURVIV. 2014;8(3):384-93.

Collection of vaccination data in the German National Cohort: Findings of a feasibility study in three study centers
Schultze A, Akmatov M, Castell S, Karch A, Ahrens W, Günther K, Schlenz H, Flesch-Janys D, Obi N, Pessler F, Krause G
BUNDESGESUNDHEITSBLATT. 2014;57(11):1292-9.

Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake
Seibold P, Vrieling A, Heinz J, Obi-Osius N, Sinn H, Flesch-Janys D, Chang-Claude J
CANCER EPIDEMIOL. 2014;38(4):419-26.

Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis
Seibold P, Vrieling A, Johnson T, Buck K, Behrens S, Kaaks R, Linseisen J, Obi-Osius N, Heinz J, Flesch-Janys D, Chang-Claude J
INT J CANCER. 2014;135(4):923-33.

Evaluation of a questionnaire to assess selected infectious diseases and their risk factors: findings of a multicenter study
Sievers C, Akmatov M, Kreienbrock L, Hille K, Ahrens W, Günther K, Flesch-Janys D, Obi-Osius N, Michels K, Fricke J, Greiser K, Kaaks R, Peter H, Pessler F, Nieters A, Krause G
BUNDESGESUNDHEITSBLATT. 2014;57(11):1283-91.

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A, Seibold P, Johnson T, Heinz J, Obi-Osius N, Kaaks R, Flesch-Janys D, Chang-Claude J
INT J CANCER. 2014;134(12):2972-83.

2013

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle A, Rudolph A, Fasching P, Hopper J, Makalic E, Schmidt D, Southey M, Beckmann M, Ekici A, Fletcher O, Gibson L, Silva I, Peto J, Humphreys M, Wang J, Cordina-Duverger E, Menegaux F, Nordestgaard B, Bojesen S, Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke C, Brenner H, Müller H, Arndt V, Stegmaier C, Brauch H, Brüning T, Harth V, Mannermaa A, Kataja V, Kosma V, Hartikainen J, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi-Osius N, Wang-Gohrke S, Couch F, Olson J, Vachon C, Giles G, Severi G, Baglietto L, Offit K, John E, Miron A, Andrulis I, Knight J, Glendon G, Mulligan A, Chanock S, Lissowska J, Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning A, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon E, Rajaraman P, Sigurdson A, Doody M, Guénel P, Pharoah P, Schmidt M, Hall P, Easton D, Garcia-Closas M, Milne R, Chang-Claude J
PLOS GENET. 2013;9(3):e1003284.

2011

Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
Obi N, Vrieling A, Heinz J, Chang-Claude J
International journal of women's health. 2011;3:37-51.

2010

The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.
Hentschel S, Heinz J, Schmid-Höpfner S, Obi-Osius N, Vettorazzi E, ChangCClaude J, Flesch-Janys D
CANCER DETECT PREV. 2010;34(5):639-643.

2009

Nonaccidental head injury is the most common cause of subdural bleeding in infants
Matschke J, Voss J, Obi-Osius N, Görndt J, Sperhake J, Püschel K, Glatzel M
PEDIATRICS. 2009;124(6):1587-1594.

The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study.
Obi-Osius N, Jenny C, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D
CANCER EPIDEM BIOMAR. 2009;18(8):2207-2213.

Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors.
Schmidt M, ChangCClaude J, Slanger T, Obi-Osius N, Flesch-Janys D, Steindorf K
METHOD INFORM MED. 2009;48(5):444-450.

Menopausal hormone therapy and risk of clinical breast cancer subtypes.
Slanger T, Chang-Claude Jenny C, Obi-Osius N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D
CANCER EPIDEM BIOMAR. 2009;18(4):1188-1196.

2008

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.
Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi-Osius N, Vettorazzi E, Braendle L, Bastert G, Hentschel S, Berger J, Chang-Claude J
INT J CANCER. 2008;123(4):933-941.

Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life.
Schmidt M, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi-Osius N, Flesch-Janys D, Jenny C
CANCER EPIDEM BIOMAR. 2008;17(12):3402-3410.

Letzte Aktualisierung aus dem FIS: 09.12.2019 - 00:37 Uhr